Cargando…

Polymorphisms in Tunisian patients with N-acetylgalactosamine-6-sulfate sulfatase gene deficiency: Implication in Morquio A disease

Mucopolysaccharidosis type IVA or Morquio A syndrome is characterized by the lack of N-acetylgalactosamine-6-sulfate-sulfatase and the accumulation of keratan sulfate and chondroitin-6-sulfate in the lysosomes. At least, 148 mutations and 16 polymorphisms were identified in the GALNS gene. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales: Khedhiri, Souhir, Chkioua, Latifa, Ferchichi, Salima, Miled, Abdelhedi, Laradi, Sandrine
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034659/
https://www.ncbi.nlm.nih.gov/pubmed/21251309
http://dx.doi.org/10.1186/1746-1596-6-11
_version_ 1782197677884178432
author Khedhiri, Souhir
Chkioua, Latifa
Ferchichi, Salima
Miled, Abdelhedi
Laradi, Sandrine
author_facet Khedhiri, Souhir
Chkioua, Latifa
Ferchichi, Salima
Miled, Abdelhedi
Laradi, Sandrine
author_sort Khedhiri, Souhir
collection PubMed
description Mucopolysaccharidosis type IVA or Morquio A syndrome is characterized by the lack of N-acetylgalactosamine-6-sulfate-sulfatase and the accumulation of keratan sulfate and chondroitin-6-sulfate in the lysosomes. At least, 148 mutations and 16 polymorphisms were identified in the GALNS gene. The aim of this study was the screening of polymorphisms within 7 patients recruited from many regions of Tunisia in order to determine the haplotypes and their association with the mutations previously reported. PATIENTS AND METHODS: We have used the PCR sequencing to analyse the different haplotypes and to identify the polymorphisms within 7 affected MPS IVA patients. RESULTS: Nine GALNS polymorphisms were detected in the 7 studied patients. Five of these polymorphisms are within the GALNS gene exons. Six polymorphisms have been previously described and used for linkage analysis in MPS IVA patients and determination of haplotypes. We have identified two novel heterozygous polymorphisms in intron 13 and intron 3 CONCLUSION: Polymorphisms may be useful for carrier detection and prenatal diagnosis in informative families whose specific mutations have not been identified. The determination of haplotypes can also determine the origin of some mutations in a population.
format Text
id pubmed-3034659
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30346592011-02-08 Polymorphisms in Tunisian patients with N-acetylgalactosamine-6-sulfate sulfatase gene deficiency: Implication in Morquio A disease Khedhiri, Souhir Chkioua, Latifa Ferchichi, Salima Miled, Abdelhedi Laradi, Sandrine Diagn Pathol Research Mucopolysaccharidosis type IVA or Morquio A syndrome is characterized by the lack of N-acetylgalactosamine-6-sulfate-sulfatase and the accumulation of keratan sulfate and chondroitin-6-sulfate in the lysosomes. At least, 148 mutations and 16 polymorphisms were identified in the GALNS gene. The aim of this study was the screening of polymorphisms within 7 patients recruited from many regions of Tunisia in order to determine the haplotypes and their association with the mutations previously reported. PATIENTS AND METHODS: We have used the PCR sequencing to analyse the different haplotypes and to identify the polymorphisms within 7 affected MPS IVA patients. RESULTS: Nine GALNS polymorphisms were detected in the 7 studied patients. Five of these polymorphisms are within the GALNS gene exons. Six polymorphisms have been previously described and used for linkage analysis in MPS IVA patients and determination of haplotypes. We have identified two novel heterozygous polymorphisms in intron 13 and intron 3 CONCLUSION: Polymorphisms may be useful for carrier detection and prenatal diagnosis in informative families whose specific mutations have not been identified. The determination of haplotypes can also determine the origin of some mutations in a population. BioMed Central 2011-01-20 /pmc/articles/PMC3034659/ /pubmed/21251309 http://dx.doi.org/10.1186/1746-1596-6-11 Text en Copyright ©2011 Khedhiri et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Khedhiri, Souhir
Chkioua, Latifa
Ferchichi, Salima
Miled, Abdelhedi
Laradi, Sandrine
Polymorphisms in Tunisian patients with N-acetylgalactosamine-6-sulfate sulfatase gene deficiency: Implication in Morquio A disease
title Polymorphisms in Tunisian patients with N-acetylgalactosamine-6-sulfate sulfatase gene deficiency: Implication in Morquio A disease
title_full Polymorphisms in Tunisian patients with N-acetylgalactosamine-6-sulfate sulfatase gene deficiency: Implication in Morquio A disease
title_fullStr Polymorphisms in Tunisian patients with N-acetylgalactosamine-6-sulfate sulfatase gene deficiency: Implication in Morquio A disease
title_full_unstemmed Polymorphisms in Tunisian patients with N-acetylgalactosamine-6-sulfate sulfatase gene deficiency: Implication in Morquio A disease
title_short Polymorphisms in Tunisian patients with N-acetylgalactosamine-6-sulfate sulfatase gene deficiency: Implication in Morquio A disease
title_sort polymorphisms in tunisian patients with n-acetylgalactosamine-6-sulfate sulfatase gene deficiency: implication in morquio a disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034659/
https://www.ncbi.nlm.nih.gov/pubmed/21251309
http://dx.doi.org/10.1186/1746-1596-6-11
work_keys_str_mv AT khedhirisouhir polymorphismsintunisianpatientswithnacetylgalactosamine6sulfatesulfatasegenedeficiencyimplicationinmorquioadisease
AT chkioualatifa polymorphismsintunisianpatientswithnacetylgalactosamine6sulfatesulfatasegenedeficiencyimplicationinmorquioadisease
AT ferchichisalima polymorphismsintunisianpatientswithnacetylgalactosamine6sulfatesulfatasegenedeficiencyimplicationinmorquioadisease
AT miledabdelhedi polymorphismsintunisianpatientswithnacetylgalactosamine6sulfatesulfatasegenedeficiencyimplicationinmorquioadisease
AT laradisandrine polymorphismsintunisianpatientswithnacetylgalactosamine6sulfatesulfatasegenedeficiencyimplicationinmorquioadisease